Diversify Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Buy
16,684
+15,792
+1,770% +$16.1M 0.33% 55
2026
Q1
$759K Sell
892
-6,690
-88% -$6.78M 0.12% 88
2025
Q4
$7.87M Sell
7,582
-1
-0% -$956 0.25% 69
2025
Q3
$6.8M Buy
7,583
+128
+2% +$95.3K 0.23% 71
2025
Q2
$4.77M Buy
7,455
+424
+6% +$329K 0.18% 92
2025
Q1
$6.22M Buy
7,031
+917
+15% +$763K 0.39% 46
2024
Q4
$4.89M Sell
6,114
-2,798
-31% -$2.32M 0.27% 55
2024
Q3
$8.1M Buy
8,912
+1,031
+13% +$927K 0.44% 42
2024
Q2
$7.35M Buy
7,881
+4,788
+155% +$3.83M 0.4% 45
2024
Q1
$2.35M Buy
+3,093
New +$2.2M 0.14% 146

Other funds holding LLY

Diversify Advisory Services's LLY Position: Q2 2026 in Review

Diversify Advisory Services increased its Eli Lilly (LLY) stake by 1,770% in Q2 2026, buying an estimated $16.1M and bringing the position to 16,684 shares worth $20M. The position accounts for 0.33% of the portfolio, ranked #55.

Diversify Advisory Services first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Diversify Advisory Services held 16,684 shares of Eli Lilly worth $20M as of Q2 2026.
  • Diversify Advisory Services bought 15,792 Eli Lilly shares in Q2 2026, an estimated $16.1M.
  • Eli Lilly made up 0.33% of Diversify Advisory Services's portfolio in Q2 2026, its #55 holding.
  • Diversify Advisory Services first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.